NEW YORK (Reuters) -Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's ...

Could this be a new era of preventative cancer medicine?

Ascension St. Vincent's St. Johns is 1 of 8 hospitals offering a new non-surgical weight-loss procedure. Patients and doctor ...

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

U.S. economy is experiencing ‘death by a thousand cuts’, says Deutsche Bank, as confidence in national debt management erodes ...

The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.